Why the UK must put medicines at the forefront of a new EU relationship Why the UK’s priorities need to change in terms of medicines regulation, which will ultimately determine whether future patients will benefit from affordable medicines supply.…
Ministers need a new approach to generic medicines Despite underpinning the fight against COVID-19, generic and biosimilar medicines do not get the attention they deserve from the UK government.…
